Physician profile
Hope Tindle
NPI 1740850965
$9,328.00
in general payments reported to CMS, 2019-2025
12 companies · $1,717 in 2025
The $1,717 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $7,152 · 2023: $319 · 2024: $140 · 2025: $1,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,396 · Food and Beverage: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,395.67 |
| Food and Beverage | $779.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,125.76 | 2022 | |
| Inspire Medical Systems, INC. | $1,734.74 | 2024-2025 | Inspire |
| Prime Surgical, LLC | $904.51 | 2022 | |
| Heron Therapeutics, INC. | $122.11 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $122.11 | 2023 | Andexxa |
| Amgen INC. | $82.79 | 2023 | Evenity |
| Medtronic, INC. | $73.09 | 2025 | Propel, Nim Vital |
| Ucb, INC. | $57.91 | 2023 | |
| Si-Bone, INC. | $33.13 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $30.52 | 2024-2025 | Dupixent |
| Vericel Corporation | $22.79 | 2023 | Maci |
| Genzyme Corporation | $18.54 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hope Tindle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.